成纤维细胞生长因子23、klotho 蛋白在慢性肾脏病心血管并发症中作用的研究进展

doi:10.3969/j.issn.1671-4091.2022.01.013

摘要/Abstract

中图分类号:

R692.5

朱依伊, 殷勋 . 成纤维细胞生长因子23、klotho 蛋白在慢性肾脏病心血管并发症中作用的研究进展[J]. 中国血液净化, 2022, 21(01): 55-58.

1. Hu, M. C.; Shiizaki, K.; Kuro-o, M.; Moe, O. W., Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annual review of physiology 2013, 75, 503-33.
2. Chen, G.; Liu, Y.; Goetz, R.; Fu, L.; Jayaraman, S.; Hu, M. C.; Moe, O. W.; Liang, G.; Li, X.; Mohammadi, M., α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling. Nature 2018, 553 (7689), 461-466.
3. Kuro-o, M.; Matsumura, Y.; Aizawa, H.; Kawaguchi, H.; Suga, T.; Utsugi, T.; Ohyama, Y.; Kurabayashi, M.; Kaname, T.; Kume, E.; Iwasaki, H.; Iida, A.; Shiraki-Iida, T.; Nishikawa, S.; Nagai, R.; Nabeshima, Y. I., Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997, 390 (6655), 45-51.
4. Kuro, O. M.; Moe, O. W., FGF23-αKlotho as a paradigm for a kidney-bone network. Bone 2017, 100, 4-18.
5. Lindberg, K.; Amin, R.; Moe, O. W.; Hu, M. C.; Erben, R. G.; ?stman Wernerson, A.; Lanske, B.; Olauson, H.; Larsson, T. E., The kidney is the principal organ mediating klotho effects. Journal of the American Society of Nephrology : JASN 2014, 25 (10), 2169-75.
6. Mu?oz-Casta?eda, J. R.; Herencia, C.; Pendón-Ruiz de Mier, M. V.; Rodriguez-Ortiz, M. E.; Diaz-Tocados, J. M.; Vergara, N.; Martínez-Moreno, J. M.; Salmerón, M. D.; Richards, W. G.; Felsenfeld, A.; Kuro, O. M.; Almadén, Y.; Rodríguez, M., Differential regulation of renal Klotho and FGFR1 in normal and uremic rats. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2017, 31 (9), 3858-3867.
7. Shikida, Y.; Mizobuchi, M.; Yoshitake, O.; Kato, T.; Ogata, H.; Koiwa, F.; Honda, H., Lower soluble Klotho levels in the pretransplant period are associated with an increased risk of renal function decline in renal transplant patients. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2021, 25 (3), 331-340.
8. Rodríguez-Ortiz, M. E.; Díaz-Tocados, J. M.; Mu?oz-Casta?eda, J. R.; Herencia, C.; Pineda, C.; Martínez-Moreno, J. M.; Montes de Oca, A.; López-Baltanás, R.; Alcalá-Díaz, J.; Ortiz, A.; Aguilera-Tejero, E.; Felsenfeld, A.; Rodríguez, M.; Almadén, Y., Inflammation both increases and causes resistance to FGF23 in normal and uremic rats. Clinical science (London, England : 1979) 2020, 134 (1), 15-32.
9. Cui, W.; Leng, B.; Wang, G., Klotho protein inhibits H(2)O(2)-induced oxidative injury in endothelial cells via regulation of PI3K/AKT/Nrf2/HO-1 pathways. Canadian journal of physiology and pharmacology 2019, 97 (5), 370-376.
10. Norris, K. C.; Olabisi, O.; Barnett, M. E.; Meng, Y. X.; Martins, D.; Obialo, C.; Lee, J. E.; Nicholas, S. B., The Role of Vitamin D and Oxidative Stress in Chronic Kidney Disease. International journal of environmental research and public health 2018, 15 (12).
11. Leifheit-Nestler, M.; Haffner, D., Paracrine Effects of FGF23 on the Heart. Frontiers in endocrinology 2018, 9, 278.
12. Agoro, R.; Montagna, A.; Goetz, R.; Aligbe, O.; Singh, G.; Coe, L. M.; Mohammadi, M.; Rivella, S.; Sitara, D., Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2018, 32 (7), 3752-3764.
13. Singh, S.; Grabner, A.; Yanucil, C.; Schramm, K.; Czaya, B.; Krick, S.; Czaja, M. J.; Bartz, R.; Abraham, R.; Di Marco, G. S.; Brand, M.; Wolf, M.; Faul, C., Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease. Kidney international 2016, 90 (5), 985-996.
14. Pescatore, L. A.; Gamarra, L. F.; Liberman, M., Multifaceted Mechanisms of Vascular Calcification in Aging. Arteriosclerosis, thrombosis, and vascular biology 2019, 39 (7), 1307-1316.
15. Donate-Correa, J.; Martín-Nú?ez, E.; Hernández-Carballo, C.; Ferri, C.; Tagua, V. G.; Delgado-Molinos, A.; López-Castillo, á.; Rodríguez-Ramos, S.; Cerro-López, P.; López-Tarruella, V. C.; Felipe-García, R.; Arévalo-Gomez, M. A.; Pérez-Delgado, N.; Mora-Fernández, C.; Navarro-González, J. F., Fibroblast growth factor 23 expression in human calcified vascular tissues. Aging 2019, 11 (18), 7899-7913.
16. Jimbo, R.; Kawakami-Mori, F.; Mu, S.; Hirohama, D.; Majtan, B.; Shimizu, Y.; Yatomi, Y.; Fukumoto, S.; Fujita, T.; Shimosawa, T., Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency. Kidney international 2014, 85 (5), 1103-11.
17. B?ckmann, I.; Lischka, J.; Richter, B.; Deppe, J.; Rahn, A.; Fischer, D. C.; Heineke, J.; Haffner, D.; Leifheit-Nestler, M., FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis. International journal of molecular sciences 2019, 20 (18).
18. Zhou, X.; Chen, K.; Wang, Y.; Schuman, M.; Lei, H.; Sun, Z., Antiaging Gene Klotho Regulates Adrenal CYP11B2 Expression and Aldosterone Synthesis. Journal of the American Society of Nephrology : JASN 2016, 27 (6), 1765-76.
19. Pi, M.; Ye, R.; Han, X.; Armstrong, B.; Liu, X.; Chen, Y.; Sun, Y.; Quarles, L. D., Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II. Scientific reports 2018, 8 (1), 12398.
20. Ding, J.; Tang, Q.; Luo, B.; Zhang, L.; Lin, L.; Han, L.; Hao, M.; Li, M.; Yu, L.; Li, M., Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway. European journal of pharmacology 2019, 859, 172549.
21. Han, X.; Cai, C.; Xiao, Z.; Quarles, L. D., FGF23 induced left ventricular hypertrophy mediated by FGFR4 signaling in the myocardium is attenuated by soluble Klotho in mice. Journal of molecular and cellular cardiology 2020, 138, 66-74.
22. Kuga, K.; Kusakari, Y.; Uesugi, K.; Semba, K.; Urashima, T.; Akaike, T.; Minamisawa, S., Fibrosis growth factor 23 is a promoting factor for cardiac fibrosis in the presence of transforming growth factor-β1. PloS one 2020, 15 (4), e0231905.
23. Huang, S. Y.; Chen, Y. C.; Kao, Y. H.; Hsieh, M. H.; Lin, Y. K.; Chung, C. C.; Lee, T. I.; Tsai, W. C.; Chen, S. A.; Chen, Y. J., Fibroblast growth factor 23 dysregulates late sodium current and calcium homeostasis with enhanced arrhythmogenesis in pulmonary vein cardiomyocytes. Oncotarget 2016, 7 (43), 69231-69242.
24. Navarro-García, J. A.; Delgado, C.; Fernández-Velasco, M.; Val-Blasco, A.; Rodríguez-Sánchez, E.; Aceves-Ripoll, J.; Gómez-Hurtado, N.; Bada-Bosch, T.; Mérida-Herrero, E.; Hernández, E.; Praga, M.; Salguero, R.; Solís, J.; Arribas, F.; Delgado, J. F.; Bueno, H.; Kuro, O. M.; Ruilope, L. M.; Ruiz-Hurtado, G., Fibroblast growth factor-23 promotes rhythm alterations and contractile dysfunction in adult ventricular cardiomyocytes. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2019, 34 (11), 1864-1875.
25. Graves, J. M.; Vallejo, J. A.; Hamill, C. S.; Wang, D.; Ahuja, R.; Patel, S.; Faul, C.; Wacker, M. J., Fibroblast growth factor 23 (FGF23) induces ventricular arrhythmias and prolongs QTc interval in mice in an FGF receptor 4-dependent manner. American journal of physiology. Heart and circulatory physiology 2021, 320 (6), H2283-h2294.

[1]	吴志茹, 王梦慈, 吴雪平, 陈卫东. 血清去磷酸化未羧化基质Gla 蛋白和维生素K2水平与慢性肾脏病患者血管钙化相关性研究[J]. 中国血液净化, 2022, 21(04): 253-257.
[2]	张松雨, 姚明杨, 周晓铎. Ⅰ型心肾综合征患者血清脑钠肽、胱抑素C、肾损伤分子水平及与急性肾损伤的相关性和预测价值[J]. 中国血液净化, 2022, 21(04): 231-234.
[3]	毕江丽, 方敬爱, 张晓东, 李慧, 张紫媛, 胡雅玲. 慢性肾脏病中肠粘膜屏障损伤研究进展[J]. 中国血液净化, 2021, 20(12): 846-848.
[4]	刘紫琦, 杜玄一. 细胞焦亡在急性肾损伤中的研究进展[J]. 中国血液净化, 2021, 20(11): 762-765.
[5]	赵立希, 于艳, 马迎春. 慢性肾脏病肌肉萎缩机制的研究进展[J]. 中国血液净化, 2021, 20(10): 654-656.
[6]	李莹莹, 李靖, 邢广群. 尿毒症患者异常升高的甲状旁腺激素水平与营养和衰弱状态的关系研究[J]. 中国血液净化, 2021, 20(09): 608-611.
[7]	叶楠, 程虹. 改善终末期肾病患者心力衰竭的新疗法[J]. 中国血液净化, 2021, 20(07): 441-444.
[8]	马晓迎, 生玉平, 杨星梦, 王娜, 张浩然, 徐海平, 孙福云. 终末期肾病患者腹主动脉钙化和心脏瓣膜钙化的临床特点及危险因素的差异分析[J]. 中国血液净化, 2021, 20(07): 460-464.
[9]	张菁菁, 曹新岭, 王顺. Klotho 蛋白在缺血再灌注急性肾损伤中的动态变化[J]. 中国血液净化, 2021, 20(04): 258-262.
[10]	杨枫, 林评兰, 邹赟, 叶朝阳. Klotho 在慢性肾脏病血管钙化中作用的研究进展[J]. 中国血液净化, 2021, 20(03): 189-192.
[11]	邢爱荣, 王雪荣, 陶舒曼, 王德光. 慢性肾脏病3～5 期患者冠状动脉钙化危险因素分析及其与铁代谢指标的相关性[J]. 中国血液净化, 2021, 20(02): 77-81.
[12]	史书君, 王文革, 梁耀军. 非透析慢性肾脏病患者的多学科医疗管理效果探讨[J]. 中国血液净化, 2021, 20(02): 82-85.
[13]	杜雯雯, 王晓星, 陈文倩, 张丹, 张相林, 李朋梅. RIFLE、AKIN 和KDIGO 急性肾损伤诊断标准在肺移植术后的应用比较[J]. 中国血液净化, 2021, 20(02): 95-98.
[14]	金方霞, 贾媛媛, 杜玄一. 慢性肾脏病和心力衰竭患者高钾血症的现状及治疗[J]. 中国血液净化, 2020, 19(12): 837-839.
[15]	赵亚, 王俭勤. H 型高血压在慢性肾脏病中的研究进展[J]. 中国血液净化, 2020, 19(11): 768-771.

成纤维细胞生长因子23、klotho 蛋白在慢性肾脏病心血管并发症中作用的研究进展

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价